SB1258 - 104th General Assembly (2025-2026)

PRIOR AUTH-PRESCRIPTION DRUGS
Last Action

1/27/2026 - Senate: Re-assigned to Insurance
Statutes Amended In Order of Appearance

Synopsis As Introduced

Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
Actions

DateChamberAction
1/28/2025SenateFiled with Secretary by Sen. Graciela Guzmán
1/28/2025SenateFirst Reading
1/28/2025SenateReferred to Assignments
3/04/2025SenateAdded as Co-Sponsor Sen. Rachel Ventura
3/12/2025SenateAssigned to Insurance
3/21/2025SenateRule 2-10 Committee Deadline Established As April 4, 2025
4/04/2025SenateRule 2-10 Committee Deadline Established As April 11, 2025
4/11/2025SenateRule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025
5/09/2025SenateRule 3-9(a) / Re-referred to Assignments
1/27/2026SenateRe-assigned to Insurance
2/27/2026SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Graciela Guzmán
2/27/2026SenateSenate Committee Amendment No. 1 Referred to Assignments